Verum Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -6.41%
- Profit Growth -10.81%
- Ebitda -11.50%
- Net Worth -281.79%
- Total Assets 42.49%
About Verum Pharmaceuticals
Verum Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2018 (Six years and nine months 19 days old ). Its registered office is in Cachar, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Garima Agarwala, Mithun Roy, Arun Sipani, and Four other members serve as directors at the Company.
Company Details
-
Location
Cachar, Assam, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304AS2018PTC018491
-
Company No.
018491
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Apr 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Verum Pharmaceuticals?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujata Choudhury
|
Director | 27-Apr-2018 | Current |
|
Garima Agarwala
|
Director | 26-Jun-2018 | Current |
|
Mithun Roy
|
Director | 27-Apr-2018 | Current |
|
Arun Sipani
|
Director | 01-Apr-2021 | Current |
|
Anjali Dutta
|
Director | 01-Jun-2018 | Current |
| Gouri Paul | Director | 08-Nov-2022 | Current |
Financial Performance of Verum Pharmaceuticals.
Verum Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.41% decrease. The company also saw a substantial fall in profitability, with a 10.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 281.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Verum Pharmaceuticals?
In 2023, Verum Pharmaceuticals had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gaurab India Private LimitedGarima Agarwala is a mutual person
-
Unnoto Health Private Limited
Garima Agarwala is a mutual person
-
Hemoprobha Prokashani Private Limited
Sujata Choudhury is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Verum Pharmaceuticals?
Unlock and access historical data on people associated with Verum Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Verum Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Verum Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
